Karyopharm Therapeutics | KPTI - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 72M 10M 2025-09
Abbott USD 78M 1000K 2025-12
AstraZeneca USD 85M 17M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Eli Lilly USD 65M 25M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
J&J USD 2.14 237M 2026-03
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 1.53M 114K 2025-09
Merck USD 96M 27M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Takeda JPY 87.87B 43.48B 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Xencor USD 6.54M 710K 2025-09